1. 817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties. (9th November 2020) Authors: Blayo, Anne-Laure; Deshons, Laurène; Dumont, Alexia; Franchet, Christel; Halter, Célia; Herbin, Ludovic; Hommet, Gaël; Mayer, Stanislas; Bessede, Alban; Nafia, Imane; Sidhoum, Marjorie; Leroy, Xavier; Schann, Stéphan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties. (9th November 2020) Authors: Blayo, Anne-Laure; Deshons, Laurène; Dumont, Alexia; Franchet, Christel; Halter, Célia; Herbin, Ludovic; Hommet, Gaël; Mayer, Stanislas; Bessede, Alban; Nafia, Imane; Sidhoum, Marjorie; Leroy, Xavier; Schann, Stéphan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗